Arqule, Inc.
Records under this name other than the patents Arqule, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 55 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,642,847 | Combinational compositions and methods for treatment of cancer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,829,560 | 1,4-disubstituted naphthalenes as inhibitors of P38 MAP kinase Term ended Term ended Apr 10, 2026 · From the USPTO record | Term ended | Term ended Apr 10, 2026 | From the USPTO record |
| US 9,447,088 | Compositions and methods for treatment of cancer Term ended Term ended Apr 6, 2026 · From the USPTO record | Term ended | Term ended Apr 6, 2026 | From the USPTO record |
| US 8,754,078 | Compositions and methods for treatment of cancer Term ended Ended no later than Feb 9, 2026 · From the USPTO record | Term ended | Ended no later than Feb 9, 2026 | From the USPTO record |
| US 8,114,873 | 1,4-disubstituted naphthalenes as inhibitors of p38 map kinase Term ended Term ended Jul 8, 2025 · From the USPTO record | Term ended | Term ended Jul 8, 2025 | From the USPTO record |
| US 10,766,868 | Methods for preparing substituted 5,6-dihydro-6-phenylbenzo[f]isoquinolin-2-amine Lapsed on the fee record Ended Sep 8, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 8, 2024 | From the USPTO record |
| US 10,717,710 | Solid forms of substituted 5,6-dihydro-6-phenylbenzo[F]isoquinolin-2-amine compounds Lapsed on the fee record Ended Jul 21, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jul 21, 2024 | From the USPTO record |
| US 7,307,079 | 1,3,5-Triazine derivatives as ligands for human adenosine-A3 receptors Formerly held Term ended Term ended Nov 2, 2023 · From the USPTO record | Term ended | Term ended Nov 2, 2023 | From the USPTO record |
| US 6,770,649 | 1-[1-(hetero)aryl-1-perhydroxyalkylmethyl]-piperazine compounds, process for their preparation and pharmaceutical compositions containing them Term ended Term ended Sep 19, 2022 · From the USPTO record | Term ended | Term ended Sep 19, 2022 | From the USPTO record |
| US 7,074,824 | Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same Term ended Term ended Jun 27, 2022 · From the USPTO record | Term ended | Term ended Jun 27, 2022 | From the USPTO record |